Validation and Acceptability of the Mobile App Version of the Control of Allergic Rhinitis and Asthma Test for

Dulce Abreu da Mata1, Inês Pais-Cunha1, Sandra Catarina Ferraz2

  • 1Unidade Autónoma de Gestão da Mulher e Criança, Pediatrics Department, Unidade Local de Saúde São João, Porto, Portugal.

PubMed

Insights

The electronic Control of Allergic Rhinitis and Asthma Test for Children (CARATKids) is validated and equivalent to the paper version. This digital tool can improve pediatric telemonitoring for asthma and allergic rhinitis.

Area of Science:

  • Pediatric Pulmonology
  • Digital Health
  • Health Measurement Validation

Background:

  • The electronic Control of Allergic Rhinitis and Asthma Test for Children (CARATKids) shows promise for pediatric telemonitoring.
  • Validation of the electronic CARATKids against its paper-based counterpart is necessary.

Purpose of the Study:

  • To validate the electronic CARATKids questionnaire against the established paper-based version.
  • To assess the reliability and agreement between the two CARATKids formats.

Main Methods:

  • A cross-sectional study involving 51 children with asthma or allergic rhinitis and their caregivers.
  • Comparison of paper and electronic CARATKids versions administered in a randomized order.
  • Analysis of internal consistency, reliability (ICC, Bland-Altman), and convergent validity (Spearman correlation) following COSMIN guidelines.

Main Results:

  • The electronic CARATKids demonstrated excellent reliability (ICC=0.95) and strong agreement with the paper version (Spearman correlation=0.95).
  • Internal consistency was high for both versions (paper: 0.79, electronic: 0.83).
  • A significant proportion of participants preferred the electronic version, indicating good acceptance.

Conclusions:

  • The electronic CARATKids is equivalent to the paper-based version, showing high validity and reliability.
  • The digital format is well-accepted by children and caregivers.
  • Implementation via mobile health technologies can enhance remote monitoring and management of pediatric asthma and allergic rhinitis.
Abstract